Insider filing · ANIP
Thomas Andrew Rowland
SVP, HEAD - ESTABLISHED BRANDS
profile →
ANI Pharmaceuticals, Inc.
ANIP · Healthcare · 50 filings in 24 months
ticker →
Thomas Andrew Rowland sold $426K of ANI Pharmaceuticals (ANIP)
Executed Aug 12 2025, disclosed Aug 14 2025, 2 days later.
Value, as filed
$426K
4,975 sh × $85.71
Executed
Aug 12 2025
the trade date, as filed
Disclosed
Aug 14 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
TRThomas Andrew Rowland (SVP, HEAD - ESTABLISHED BRANDS) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $357K of ANIP (4,772 sh × $74.91, as filed), executed Mar 11.
The name
ANIPHealthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Thomas Andrew Rowland in ANIP
ANIPSALE
ANI Pharmaceuticals, Inc.
$357K4,772 sh × $74.91
Exec Mar 11
Filed Mar 13 · 5:30 PM ET